NBY logo
NovaBay Pharmaceuticals, Inc.(NBY)
$1.47—Stale · unknown old

Trailing Twelve Months (TTM) Metrics

Per Share (TTM)
Revenue/Share$0.15
Net Income/Share$15.57
Operating CF/Share$-0.38
Free CF/Share$-0.38
Cash/Share$0.22
Book Value/Share$4.10
Tangible Book/Share$0.26
Equity/Share$4.10
Interest Debt/Share$0.01
CapEx/Share$0.00
Dividend/Share$4.00
Valuation (TTM)
Market Cap$74.16M
Enterprise Value$67.19M
P/E Ratio0.10P/S Ratio15.88
P/OCF Ratio-3.84
P/FCF Ratio-6.24
P/B Ratio0.36
P/TB Ratio0.36
EV/Sales14.39
EV/EBITDA-10.27
Graham Valuation
Graham Number$37.89
Graham Net-Net$0.22
Profitability (TTM)
Earnings Yield1059.24%FCF Yield-16.02%ROE789.69%ROIC-5.18%Return on Tangible Assets5844.34%
Dividend (TTM)
Dividend Yield272.11%Payout Ratio1.00%
Capital Allocation
CapEx/OCF0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue0.00%
SG&A/Revenue240.12%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00
Debt/Market Cap0.00
Net Debt/EBITDA1.07
Current Ratio29.98Interest Coverage-29.28xIncome Quality-0.02
Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding0 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.00x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$8.00M
Working Capital$7.83M
Invested Capital$127.07M
Intangibles/Assets93.51%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.